An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color
Journal of Drugs in Dermatology · 2024
DOI: 10.36849/jdd.7897 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Drugs in Dermatology, 2024. Verfasst von Nour El-Kashlan und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acne Vulgaris, Administration, Cutaneous, Dapsone, Severity of Illness Index. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
El-Kashlan, N., Cices, A., Kaufman, B., Da Rosa, J. C., Sanabria-Gonzalez, I., Khattri, S., & Alexis, A. (2024). An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7897
Vancouver
El-Kashlan N, Cices A, Kaufman B, Da Rosa JC, Sanabria-Gonzalez I, Khattri S, et al. An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.7897
BibTeX
@article{ElKashlan2024,
author = {El-Kashlan, Nour and Cices, Ahuva and Kaufman, Bridget and Da Rosa, Joel Correa and Sanabria-Gonzalez, Ingrid and Khattri, Saakshi and Alexis, Andrew},
title = {An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color},
journal = {Journal of Drugs in Dermatology},
year = {2024},
doi = {10.36849/jdd.7897}
}
EUVIMED